Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-3 of 3

Sort by

Sort Order Select

Journal Articles

Prospective Trial Using Multimodal Measurable Residual Disease Negativity to Guide Discontinuation of Maintenance Therapy in Multiple Myeloma (MRD2STOP)

Ben A. Derman, Ajay Major, Sarah Major, Brittany D. Wolfe, Martha Gorski, Jennifer H. Cooperrider, Evangelia Andreatos, Ken Jiang, Karson Buckley, Amanda McIver, Andrew Stefka, Andrzej Jakubowiak

Blood (2022) 140 (Supplement 1): 2108–2109.

https://doi.org/10.1182/blood-2022-158643

Published: 2022

Journal Articles

Global Health Status Inadequately Captures Longitudinal Changes in Quality of Life in Patients Receiving Carfilzomib for Multiple Myeloma: Electronic Patient-Reported Outcomes (ePROs) from a Prospective Observational Study

Ajay Major, Nicole Prabhu, Claire Cunningham, Jennifer H. Cooperrider, Hannah Johnston, Evangelia Andreatos, Martha Gorski, Sarah Major, Brittany D. Wolfe, Eric Kruse, Ben A. Derman, Roberto M. Lang, Andrzej Jakubowiak, Jeanne DeCara

Blood (2022) 140 (Supplement 1): 12593–12595.

https://doi.org/10.1182/blood-2022-157795

Published: 2022

Journal Articles

A Phase 2 Study of Extended Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Newly Diagnosed Multiple Myeloma

Ben A Derman, Ajay Major, Jacalyn Rosenblatt, David Avigan, Murtuza M. Rampurwala, Luis Alcantar, Bernadette M. Libao, Amanda McIver, Evangelia Andreatos, Sarah Major, Brittany Wolfe, Martha Gorski, Theodore G. Karrison, Andrew Stefka, Andrzej Jakubowiak

Blood (2021) 138 (Supplement 1): 2759.

https://doi.org/10.1182/blood-2021-151832

Published: 2021